Komodo Health is a healthcare-data and AI company whose 'Healthcare Map' and Marmot AI turn real-world evidence — 330M+ patient journeys — into commercial and clinical intelligence for life sciences teams (field targeting, HCP messaging, market landscapes, RWE studies). Its LinkedIn program is high-volume but built on a very small master creative set: a signature 'conference demo clip' format (a Komodo presenter on stage beside a Marmot product screen) re-cut into many messages, plus a couch-interview series, dark branded title-cards, an executive thought-leadership post, and a build-vs-buy webinar. Every ad is paid for by Komodo Health.
How Komodo Health advertises: Komodo runs a disciplined, heavily copy-tested program: 220+ live ads off roughly half a dozen master formats. The workhorse is a 'conference demo clip' — the same Komodo-branded stage footage of a presenter next to a giant Marmot screen — re-cut and re-captioned for each use case: building a rep's daily call list ('Marmot predicts which providers have a patient about to begin treatment'), grounding outreach in claims ('Marmot turns patient-level claims into the message each provider needs to hear next,' featuring an Ochsner Health System example), on-label call strategy ('cleared by medical and marketing'), HCP prioritization ('turns them into a ranked, ready-to-run 30-day plan'), and market drill-down ('see the full treatment landscape, then narrow to a single practice'). A second format is a polished two-person couch interview, also re-cut by message — 'Change management with AI doesn't have a finish line' ('Make AI adoption your competitive edge') and 'The quickest way to create value with AI isn't building all the infrastructure yourself' ('Give leadership a growth story, not a savings story'). A third is a dark, minimalist branded title-card for the data story — 'Marmot streams 330M+ research-ready patient journeys to your team on day one' and 'insights reach your team in minutes… no exports' ('research-ready data, no exports'). Rounding it out: an executive thought-leadership post from President Miles Ennis ('Build vs. buy isn't really a technology decision. It's a trust decision') and the webinar it drives to — 'Build vs. Buy: Lessons from a Top 10 Pharma on Their AI Journey,' co-starring Merck's Director of AI Agents. Nearly every unit closes on 'Request Demo.' The strategy: prove Marmot with real, specific product moments; test messaging aggressively over a tiny, reusable creative base.
A very small master set — one demo-clip format, one interview, dark data cards, an exec post and a webinar — copy-tested at high volume (220+ live ads).
| Format | What Komodo Health uses it for |
|---|---|
| 'Conference demo clip' videos | one stage-plus-Marmot-screen master re-cut into many use-case messages |
| Couch-interview series | a two-person interview re-cut by message (AI adoption, growth vs. savings) |
| Dark branded title-cards | minimalist data-story cards (330M+ journeys, research-ready, no exports) |
| Executive thought leadership | a President Miles Ennis 'build vs. buy is a trust decision' post |
| Webinar | 'Build vs. Buy: Lessons from a Top 10 Pharma' with Merck's AI lead |
Live Komodo Health creatives with their full ad copy (verbatim), format, theme and CTA.
"Verbatim intro: "Build vs. buy. It's the question every life sciences AI team eventually has to answer." A webinar creative (Sept 24) with John Wollman (GM, Marmot Go-To-Market, Komodo), Ritu Saxena, PhD (Director of AI Agents, Merck) and Lanie Schenkelberg (VP Product Marketing, Komodo) — borrowing a top-pharma voice for the buy case."
"Verbatim intro: "Instead of reps deciding on a hunch where to spend the day, Marmot predicts which providers have a patient about to begin treatment and builds the call list." A stage demo clip (captioned 'We started the other example with'), CTA 'Point every rep to the provider with a patient about to start therapy.'"
"Verbatim intro: "Your best reps still start the day guessing which account to visit. Marmot turns patient-level claims into the message each provider needs to hear next." A demo clip showing an Ochsner Health System HCP sales report, CTA 'Drive provider outreach with messaging grounded in real patient data.'"
"Verbatim intro: "When the data already lives where you build, insights reach your team in minutes instead of weeks. No exports, no platform switching, no waiting on a handoff." A dark branded title-card ('Getting external healthcare data into…'), CTA 'Healthcare data without the exports. Book a demo.'"
"Verbatim intro: "Change management with AI doesn't have a finish line. The teams that get real value out of it treat it as an ongoing process, adopting a learning mindset to keep what works, drop what doesn't, and adjust." A two-person couch interview, CTA 'Make AI adoption your competitive edge.'"
"Verbatim intro: "Marmot turns what a provider prescribes today into the clinical point your rep opens with, tailored to their patients and cleared by medical and marketing." A demo clip showing a 'CALL STRATEGY' screen, CTA 'Drive on-label messaging built on real prescribing data with Marmot.'"
"Verbatim: "Build vs. buy isn't really a technology decision. It's a trust decision. Every life sciences AI team I talk to eventually lands on the same s[pot]…" A promoted post from President Miles Ennis over a dark KOMODO brand card, linking to the 'Build vs. Buy' webinar ('Merck's AI lead joins Komodo… Register for this live webinar')."
"Verbatim intro: "Real-world evidence is only as good as the data underneath it. Marmot streams 330M+ research-ready patient journeys to your team on day one." A dark branded title-card, CTA 'Book a demo: research-ready data, no exports.'"
"Verbatim intro: "Not every HCP is a priority right now. Marmot flags the ones with several high-risk patients and turns them into a ranked, ready-to-run 30-day plan." A demo clip (captioned 'Another example that I also'), CTA 'Know which HCPs to engage first, and what to do next.'"
"Verbatim intro: "Marmot allows you to see the full treatment landscape, then narrow to the practice, adjusting for geography, site type, and access to care as you go." A demo clip (captioned 'I think that from here you can imagine your…'), CTA 'See every level of the market, down to a single practice.'"
"Verbatim intro: "The quickest way to create value with AI isn't building all the infrastructure yourself. It's leveraging a proven platform that can drive growth." A second cut of the couch interview (captioned 'We said we want a platform'), CTA 'Give leadership a growth story, not a savings story.'"
All creatives shown belong to Komodo Health (komodohealth.com, the healthcare-data / real-world-evidence company behind the Healthcare Map and Marmot AI) and are reproduced verbatim from the LinkedIn Ad Library for commentary and analysis. Every ad shown is paid for by Komodo Health. Named individuals and third parties appear in Komodo's own creative: Komodo team members Miles Ennis (President), John Wollman and Lanie Schenkelberg; Ritu Saxena, PhD (Merck) as a webinar guest; and Ochsner Health System referenced within a product-demo example. Komodo copy-tests a very small master set (notably one 'conference demo clip' format) across 220+ live ads, so several creatives here share that format while carrying distinct messages — shown deliberately to illustrate that high-volume copy-testing model. This page was built in place of Datavant, which could not be cleanly isolated in the LinkedIn Ad Library; both are healthcare-data companies. Digital Astronauts is not affiliated with Komodo Health.
Komodo runs 220+ live ads off roughly half a dozen masters — most visibly a single 'conference demo clip' re-cut into call-list, messaging, on-label, prioritization and market-drill-down versions. A strong, reusable creative base lets you test many messages cheaply and stay instantly recognizable.
Instead of abstract claims, the demo clips show Marmot doing one concrete job on a real screen (an Ochsner HCP report, a call-strategy for a named drug, a ranked 30-day plan). Showing the product doing the work is more convincing than describing it.
Komodo splits its message: dark title-cards carry the data credibility ('330M+ research-ready patient journeys,' 'no exports'), while demo clips carry the day-to-day workflow value. Giving each pillar its own format keeps both arguments clear.
The interview series explicitly coaches buyers to 'give leadership a growth story, not a savings story.' Naming the frame you want the buyer to use with their own executives is a sharp, repeatable positioning move.
For the fraught build-vs-buy question, Komodo puts Merck's Director of AI Agents on the webinar and its own President ('it's a trust decision') on the post. Borrowing a top-pharma voice de-risks the 'buy' case better than the vendor asserting it alone.
We build LinkedIn and paid programs for high-consideration B2B and healthcare buyers — measured on pipeline, not impressions.
Book a free ad auditWith a high-volume but tightly copy-tested program paid for by Komodo Health: a signature 'conference demo clip' format (a presenter beside a Marmot product screen) re-cut into many use-case messages, a two-person couch-interview series, dark branded data-story title-cards (330M+ journeys, research-ready, no exports), an executive thought-leadership post from President Miles Ennis, and a 'Build vs. Buy' webinar with Merck's AI lead — nearly all closing on 'Request Demo.'
That Marmot turns Komodo's real-world Healthcare Map (330M+ research-ready patient journeys) into specific, ready-to-act commercial and clinical intelligence for life sciences teams — better call lists, claims-grounded HCP messaging, on-label call strategy, prioritization and market landscapes — delivered where teams already work, with no exports.
Because it copy-tests a small master set at high volume: one 'conference demo clip' format is re-cut and re-captioned for each use case, and its interview and data-card formats are reused the same way. The 220+ live ads are mostly message variants of a handful of masters, not distinct concepts — a deliberate, efficient testing model.
Build one strong, reusable master format and copy-test messages on it; prove the product with specific, real on-screen moments instead of abstract claims; give your data-credibility story and your workflow-value story separate formats; reframe the category the way you want buyers to pitch it internally (growth, not savings); and let a marquee customer carry your riskiest argument.